Delivery Order SPE2DR25D3301-SPE2DR26F18MS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,075.62 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Injectafer is an intravenous iron replacement therapy used in the treatment of iron...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $13,079.20. This competitively awarded, firm fixed-price contract is classified as a child order and represents a non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order has an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a delivery order totaling $19,186.58 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials on September 8, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The contract involves no set-aside designation, indicating open competition among...
- The Defense Logistics Agency awarded a delivery order valued at $14,143.49 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Injectafer 750 mg/15 mL vials. This firm fixed-price, non-set-aside contract is scheduled for completion by June 3, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a $13,321.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Injectafer 750 mg/15 ml vials on October 31, 2025, with completion targeted for November 3, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,270.54 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. The contract, which is not set-aside, was competitively awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. The product will be delivered to Conshohocken, Pennsylvania, utilizing a firm fixed price arrangement. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $19,856.34 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. The product...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of Injectafer (iron sucrose) 750 mg/15 mL vials. The award, valued at $17,608.31, was made on August 22, 2024 with a completion date of August 23, 2024. The contract is a firm-fixed-price type, and no set-aside was used. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $21,388.96. This non-set-aside, firm fixed price delivery order is scheduled for completion by December 4, 2025, with fulfillment based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials valued at $30,634.48. This firm fixed-price, competitively awarded contract has a completion deadline of December 15, 2025, and represents a pediatric iron supplementation product for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18MSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials, with a ceiling value of $13,146.03. This non-competitive, firm fixed-price delivery order was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025. The place of performance is AmerisourceBergen Drug Corp's corporate office in Conshohocken, Pennsylvania. This award is executed under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Injectafer is an intravenous iron replacement therapy used to treat iron deficiency anemia, making it a critical pharmaceutical for military medical supply chains. As a prime contractor on the DLA's extensive pharmaceutical IDC, AmerisourceBergen Drug Corp demonstrates significant capability in fulfilling federal medical procurement requirements across multiple therapeutic domains. The company supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency operations and other government healthcare systems. This delivery order reflects the company's ongoing role in maintaining adequate pharmaceutical inventory for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 11/23/25 |